missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ CDIP Antibody Blocking Peptide

Product Code. 18268755 Shop All Bio Techne Products
Click to view available options
Quantity:
0.05 mg
Unit Size:
0.05mg
This item is not returnable. View return policy

Product Code. 18268755

Brand: Novus Biologicals™ NBP176996PEP

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 19 amino acids near the center of human CDIP. Source: Synthetic (Accession #: NP_037531) The CDIP Blocking Peptide has been validated for the following applications: Antibody Competition.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 29965
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-76996. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias CDIP, cell death inducing protein, Cell death-inducing protein, chromosome 16 open reading frame 5, I1, LITAF-like protein, Transmembrane protein I1
Gene Symbol CDIP1
Product Type CDIP
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 19 amino acids near the center of human CDIP
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.